Compare RCKT & HKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RCKT | HKD |
|---|---|---|
| Founded | 1999 | 2003 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 428.6M | 446.3M |
| IPO Year | N/A | 2022 |
| Metric | RCKT | HKD |
|---|---|---|
| Price | $3.16 | $1.45 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $30.27 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 276.4K |
| Earning Date | 02-26-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $87,436,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.54 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.19 | $1.26 |
| 52 Week High | $11.27 | $5.47 |
| Indicator | RCKT | HKD |
|---|---|---|
| Relative Strength Index (RSI) | 36.65 | N/A |
| Support Level | $3.00 | N/A |
| Resistance Level | $3.63 | N/A |
| Average True Range (ATR) | 0.20 | 0.00 |
| MACD | -0.07 | 0.00 |
| Stochastic Oscillator | 14.08 | 0.00 |
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. Its reportable segments are digital solutions services segment, hotel operations, hospitality and VIP services segment and media and entertainment services. The company generates maximum revenue by providing financial digital solutions through its insurance brokerage services and other digital solutions services. Geographically, the company generates maximum revenue from Hong Kong and Singapore.